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1.1.	Physiology of sleep 
Sleep is the restorative function of all living creatures and occupies one third of a human life. Healthy sleep restores mood and physical function of our bodies. It is linked to mood, behaviour, endocrine and immune function. It is not a uniform entity. 
The different stages of sleep were firstly classified by Rechtschaffen and Kales in 1968 (Figure 1). At the beginning of sleep, when a person is still awake but sleepy, characteristic alpha EEG (electroencephalogram) waves appear. These waves, occuring with a frequency of 8-12Hz, occur during relaxed wakefulness. About 10-20 minutes later muscle tone decreases, alpha waves disappear and slower frequency theta waves (4-7Hz) appear. This stage is called NREM (Non Rapid Eye Movement) sleep stage 1. After a few minutes of stage 1 NREM stage 2 NREM follows. During stage 2 K complexes and sleep spindles are observed. Stage 1 and 2 are known as light sleep. When awakened from these stages of sleep a person reports the event being as if they had dozed off but did not sleep. 10-20 minutes later deep sleep commences. Slow waves, called delta waves (0.5-4 Hz with high amptitudes up to 150 uV) appear on the EEG. This slow wave sleep is further divided into NREM stage 3 (with delta waves occupying 20-50% of the time) and NREM stage 4 (with  more than 50% of delta waves). After 20-40 min of slow wave sleep, rapid eye movement (REM) sleep follows. During REM sleep, the muscle tone is at its lowest and the most striking feature is rapid eye movement. 80% of persons who are awakened during REM sleep report colourful, vivid and emotional dreams. This sequence of sleep stages occur as a cycle with a duration of 80-110 min. There are 4-6 sleep cycles in a normal night sleep with the ealier cycles having more slow wave sleep and the later ones having more REM sleep. Figure 2 shows a normal hypnogram. 











Figure.2. Typical hypnogram of an adult and light gray areas represent non-rapid eye movement sleep    
1.2 Sleep Disorders and Classification
There are many different types of sleep disorder which are not widely recognised by many clinicians. The boundary between normality and disease is often difficult to establish. For example, snoring may only be a social nuisance but could also be associated with sleep fragmentation and obstructive sleep apnoea. Lack of sleep or sleep fragmentation can cause excessive daytime sleepiness, daytime dysfunction, lack of energy, have negative impacts on quality of life and cardiovascular morbidity. Most sleep clinicians refer to the 2nd International Classification of Sleep Disorders (ICSD II) to classify sleep disorders (Duchna 2006)(Table 1).

1.3 Obstructive Sleep Apnoea/ Hypopnoea Syndrome (OSAHS)
Obstructive sleep apnoea is a common disorder affecting approximately 2% of women and 4% of men.  It is characterized by repetitive episodes of partial and complete collapse of upper airway during sleep. These episodes are commonly associated with oxygen desaturation (falling blood oxygen levels) and result in fragmented sleep, changes in sleep architecture and excessive daytime somnolence. In 1837 the first description of a patient with sleep apnoea was given by Charles Dickens in ‘The Posthumous Papers of the Pickwick Club’. One of the characters, Joe Pickwick, was described as follows: 
	
 ‘... and on the box sat a fat and red-faced boy, in a state of somnolency’. 

Based on the character in this novel Sir William Osler firstly used the term ‘Pickwickians’ to refer to obese, hypersomnolent patients in 1918. In 1965, Gastault et al reported repetitive apnoea events in Pickwickian patients during sleep (Gastaut, Tassinari et al. 1966). Kuhlo et al (Kuhlo, Doll et al. 1969) reported the significant improvement following tracheostomy in patients with sleep apnoea. 


Table 1: ICSD Classification of Sleep Disorders
  I              Insomnia
(a)	Adjustment or acute insomnia




(f)	Insomnia due to mental disorder
(g)	Insomnia due to drug and substance uses and abuse
(h)	Insomnia due to medical conditions
II		Sleep-related Breathing disorders (SRBD)
(a)	Obstructive Sleep Apnoea/Hypopnoea Syndrome
(b)	Central Sleep Apnoea Syndrome with Cheyne-Stokes Respiration
(c)	Central Sleep Apnoea Syndrome
(d)	Obesity Hypoventilation Syndrome
     III          	Hypersomnia
(a)	Narcolepsy
(b)	Idiopathic Hypersomnia                                                                                                         
V              Circadian Rhythm Sleep Disorder
(a)	Delayed Sleep-Phase Syndrome
(b)	Advanced Sleep-Phase Syndrome







       VI           Sleep-related Movement Disorders (Restless Legs Syndrome)
       VII          	Isolated symptoms, apparently normal variants




Risk factors for sleep apnoea include increasing age, sex, body mass index, genetic/familial factors and peculiar anatomy of the upper airway.
1.3.1.1. Age
 Obstructive sleep apnoea becomes more prevalent with increasing age. Duran et al (Duran, Esnaola et al. 2001) report, in a community based study of 2,148 subjects, the prevalence of obstructive sleep apnoea in both sexes increasing with age. The Sleep Heart Health Study reported the prevalence of Obstructive Sleep apnoea/Hypopnoea Syndrome (OSAHS) increased with age reaching a plateau after 60 years of age (Young, Peppard et al. 2002). It is thought that the deposition of fat around the pharyngeal area, change in structures around pharynx and elongation of uvula (Malhotra, Huang et al. 2006) (Eikermann, Jordan et al. 2007) may be responsible.                                                                                                                                                      

13.1.2. Sex
OSAHS has been reported to affect more men than women. The Wisconsin Sleep Cohort Study, which recruited about 600 employed men and women, estimated that the disease affects 4% of middle-aged men and 2% of middle-aged women (Young, Peppard et al. 2002). Redline et al (Redline, Kump et al. 1994) assessed the association of gender and sleep disordered breathing in 389 people. They found the prevalence of SDB to be higher in males than females with a ratio of 2:1. Female apnoea subjects were older than male counterparts. Bixler et al (Bixler, Vgontzas et al. 2001) also conducted a large community based study and found a higher prevalence of obstructive sleep apnoea in males (3.9% of males and 1.2% of females). This study also found that the prevalence of the disease is low in premenopausal women and in post-menopausal women using hormone replacement therapy. 

1.3.1.3. Body Weight and Body Mass Index (BMI)
Obesity is quantified using the body mass index (BMI; weight in kilograms divided by the square of height in meters). BMI correlates with the amount of body fat in most people. A BMI of more than 25 kg/m2 is classified as overweight, a BMI>30kg/ m2 is diagnostic of obesity and a BMI >40kg/ m2 indicates extreme obesity. The World Health Organization reported that there were more than 1 billion overweight adults globally in 2008, at least 300 millions of them being obese. According to National Health Service (NHS) information statistics 24% of adults in 2007 fell into the category of obesity compared to only 15% in 1993. 
Body weight is the strongest independent risk factor for obstructive sleep apnoea. Epidemiological studies across the world have confirmed that excess body weight is uniformly associated with an increase in prevalence of obstructive sleep apnoea (Duran, Esnaola et al. 2001),(Young, Peppard et al. 2002), (Bixler, Vgontzas et al. 2001),(Bearpark, Elliott et al. 1995),(Kim, In et al. 2004),(Ip, Lam et al. 2004). Population-based prospective cohort data from the Cleveland Familial Study (Tishler, Larkin et al. 2003) found that the apnoea hypopnoea index (AHI; the number of airway occlusions or near occlusions happening per hour) was significantly associated with BMI. The effect of BMI decreased with age and became negligible after 60 years of age. 
The Sleep Heart Health Study (Peppard, Young et al. 2000) randomly selected 2968 men and women in the community, assessed them at 5 yearly interval and reported that the respiratory disturbance index (RDI; the number of oxygen desaturation events per hour) increased with weight gain and decreased with weight loss, especially in men. The Wisconsin sleep study (Newman, Foster et al. 2005) , a large longitudinal population based cohort study, also found that a 10% weight gain predicted a 6 fold increase in AHI whereas a 10% weight loss predicted a 26% decrease in AHI.

1.3.1.4. Genetic and Familial factors 
Although specific genes causing obstructive sleep apnoea have not been identified, some studies suggest that  genetic factors may predispose to OSAHS  through influence on  craniofacial structure, body fat distribution and neural control of the upper airway (Redline and Tishler 2000). The Cleveland Familial Study of Sleep Disordered Breathing (Redline, Tishler et al. 1995) assessed 561 members of 91 families. Sleep disordered breathing (SDB) was more prevalent in the relatives of patients with SDB (21%) compared to control subjects (12%; p=0.02). 
The effect of racial background on the prevalence of OSAHS is under debate. Difference in age of presentation and anatomical risk factors in different racial group suggests the possibility of genetics as a predisposing factor for sleep apnoea. Ancoli-Isreal et al (Ancoli-Israel, Kripke et al. 1991), in a community based epidemiological study in San Diego, reported a 2.5 fold increase of having an AHI more than 30 in African-Americans compared to Caucasians. 

1.3.1.5. Anatomy of upper airway
Some patients with obstructive sleep apnoea are not obese and abnormal narrowing of the upper airway may be the major contributory factor for the development of OSAHS. Mortimore et al (Mortimore, Marshall et al. 1998) proved that neck tissue volume was 10% greater in non-obese OSAHS patients and 28% greater in obese patients with OSAHS than in control groups. Stradling et al (Stradling and Crosby 1991), in a study of 1001 middle aged men, found that neck circumferences greater than 48 cm was a strong independent  predictor for obstructive sleep apnoea. 
Some phenotypic features can cause upper airway abnormalities and predispose OSAHS. Craniofacial abnormalities (retrognathia, micrognathia and mandibular hypoplasia), macroglossia (in patients with Down’s syndrome and acromegaly), hypertrophic tonsils and an enlarged uvula can all result in narrowing in the upper airway and predispose to OSAHS. 

1.3.2 Diagnosis of obstructive sleep apnoea
The diagnosis of sleep apnoea is based on clinical symptoms, assessment of daytime sleepiness and objective assessment of sleep disordered breathing. Various questionnaires can be used to assess the degree of daytime sleepiness but the commonest subjective questionnaire used in clinical practice is the Epworth Sleepiness Scale (ESS; Appendix 1). For objective assessment, Multiple Sleep Latency Test (MSLT; Appendix 2), Maintenance of Wakefulness Test (MWT; Appendix 3) and the Oxford Sleep Resistance test (OSLeR test; Appendix 4) are commonly used.














1.3.3. Pathophysiology of sleep apnoea
The pathophysiology of obstructive sleep apnoea has not been clearly defined. Alteration in upper airway collapsibility is thought to be the major determining factor for sleep apnoea susceptibility. Upper airway collapsibility is determined by mechanical and neurological factors (Schwartz, Rowley et al. 1996), (Schwartz, Thut et al. 1993). Schwab et al (Schwab, Gefter et al. 1993) studied the effect of respiration on upper airway calibre using computed tomography (CT) and found that upper airway circumference was significantly smaller in sleep apnoea patients than normal controls at the retropalatal and retroglossal anatomic levels. Subsequent studies of upper airway soft tissue by Schwab et al (Schwab, Pasirstein et al. 2003) using magnetic resonance imaging demonstrated that the volumes of the lateral pharyngeal wall and tongue were significantly greater in sleep apnoea patients than normal subjects. In multivariate logistic regression analysis the volumes of pharyngeal wall and tongue were shown to be independent risk factors for sleep apnoea.
Neuromuscular responses in the upper airway during sleep also contribute to airway collapse. In normal individuals there are compensatory neuromuscular reflexes that activate upper airway dilator muscles to maintain upper airway patency during sleep. Some studies have shown impaired or lost upper airway dilator neuromuscular responses in  patients with sleep apnoea (Smith, Wise et al. 1988), (Gleadhill, Schwartz et al. 1991). 

1.3.4. Clinical Presentation of Obstructive Sleep Apnoea
Obstructive sleep apnoea is emerging as a substantial public health problem across the world especially in developed countries. Most patients are referred to sleep physicians due to heavy snoring, witnessed apnoeas or excessive daytime sleepiness. Snoring is the most common presenting symptom of sleep apnoea affecting 70-95% of patients (Whyte, Allen et al. 1989). Most patients are brought to medical attention by bed partners. Witnessed apnoea is another common presentation. Bed partners report breathing pauses during sleep. Patients may report waking up with a choking feeling or feeling panicked during the night. Excessive daytime sleepiness (EDS) is common. App et al (App, Boatwright et al. 1990) reported that 80-90% of patients presenting with daytime somnolence will be diagnosed with a sleep disorder. EDS is due to sleep fragmentation due to intermittent hypoxia (low oxygen) and apnoea. Interestingly, only about a quarter of patients report sleepiness as their main symptom. Almost half of patients report lack of energy and about one quarter suffer exhaustion (Chesson, Berry et al. 2003). EDS is more pronounced in quiet and monotonous situations and is a major factor in the increased tendency to road traffic accidents in somnolent individuals (Findley, Unverzagt et al. 1988),(Lloberes, Levy et al. 2000),(Wu and Yan-Go 1996). Findley et al (Findley, Unverzagt et al. 1988) reported that patients with obstructive sleep apnoea are 7 times more likely to have a road traffic accident and that 24% of patients with OSAHS reported falling asleep while driving  at least once a week. Lloberes et al (Lloberes, Levy et al. 2000) studied road traffic accidents in 189 OSA patients over a 5 year period. Self-reported numbers of accidents were significantly higher in OSAHS patients compared to control groups and were related to self-reported sleepiness while driving (OR 5, 95%CI 2.3-10.9). 
Almost half of patients with obstructive sleep apnoea report symptoms of fatigue (Chervin 2000; Mills, Kim et al. 2008) which can be improved by CPAP treatment (Carratu, Karageorgiou et al. 2007). However, other studies suggest (Bardwell, Berry et al. 1999; Bardwell, Moore et al. 2000; Bardwell, Moore et al. 2003)  that the severity of obstructive sleep apnoea is not a significant predictor of fatigue but that symptoms of fatigue are more independently correlated with symptoms of obstructive sleep apnoea. These studies also report that treatment of obstructive sleep apnoea with CPAP does not improve fatigue.

1.3.5. Treatment of obstructive sleep apnoea
1.3.5.1. Continuous Positive Airway Pressure (CPAP)
Continuous Positive Airway Pressure is the gold standard treatment for patients with obstructive sleep apnoea. It is a device which delivers a column of continuously pressurised air to the upper airway to prevent collapse during sleep. This air splint reduces the frequency of apnoea and desaturation during sleep (Ziegler, Mills et al. 2001; Barnes, McEvoy et al. 2004). CPAP also reduces the duration of stage 1 and increases stage 3 and 4 sleep (McArdle and Douglas 2001; Barnes, McEvoy et al. 2004). The National Institute of Clinical Excellence (NICE) Technology Appraisal Guidance 139 (March 2008) recommends CPAP as first line of treatment in symptomatic patients with moderate to severe obstructive sleep apnoea. Several studies suggest that CPAP has the potential benefit of increased subjective and objective alertness, decreased cardiovascular complications, decreased incidence of hypertension, improved mood, improved cognitive function, improved functional outcomes and reduced risk of sleep related accidents (Engleman, Martin et al. 1998; Redline and Strohl 1998; Ballester, Badia et al. 1999; Engleman, Kingshott et al. 1999; Hack, Davies et al. 2000; Munoz, Mayoralas et al. 2000; Faccenda, Mackay et al. 2001; Monasterio, Vidal et al. 2001; Ferini-Strambi, Baietto et al. 2003).
Excessive daytime sleepiness is the main indication for CPAP treatment in patients with obstructive sleep apnoea. The Epworth Sleepiness Scale is widely used as a subjective assessment in most studies. Several randomised controlled studies (Jenkinson, Stradling et al. 1997; Engleman, Martin et al. 1998; Ballester, Badia et al. 1999; Hack, Davies et al. 2000; Monasterio, Vidal et al. 2001) show that CPAP has a beneficial effect on symptoms of daytime sleepiness, quality of life, self-ratings of daytime function and general well-being as measured by SF-36 (short form 36, quality of life questionnaires) and ESS. NICE recommends CPAP in mild obstructive sleep apnoea only after life style modification and other measures fail. However,  randomised controlled studies (Engleman, Kingshott et al. 1999) (Redline, Adams et al. 1998) show that some subjects with mild sleep disordered breathing patients have improved well-being, mood and functional status following CPAP treatment.


1.3.5.2. Mandibular Advancement Devices (MADs)
Mandibular advancement devices are an alternative to CPAP treatment especially in patients with mild to moderate obstructive sleep apnoea (NICE Technology Appraisal Guidance 139). They are designed to protrude the mandible preventing the occlusion of the upper airway by the tongue and epiglottis during sleep. Treatment with MADs has been found to be successful in women with obstructive sleep apnoea and reduces snoring in men with supine obstructive sleep apnoea (Marklund, Persson et al. 1998; Ferguson, Cartwright et al. 2006). MADs are less effective in reducing AHI than CPAP but are more tolerable, more acceptable and preferred by some patients (Ferguson, Ono et al. 1997; Gotsopoulos, Kelly et al. 2004). A randomised controlled trial by Gotsopoulos et al (Gotsopoulos, Kelly et al. 2004) showed that oral appliances can reduce diastolic blood pressure by 3 mmHg after 4 weeks of treatment. The adverse effects of MADs such as mucosal dryness, excessive salivation and tooth pain are usually mild (Fritsch, Iseli et al. 2001). 
1.3.5.3. Upper airway surgery
Upper airway surgical treatments include uvulopalatopharngoplasty (UPPP), laser-assisted uvulopalatoplasty (LAUP), lateral phrangoplasty and maxillomandibular advancement (MMA). UPPP is the most widely used surgical procedure in OSA and tends to be most successful in patients with mild obstructive sleep apnoea (Sher, Schechtman et al. 1996). LAUP is not recommended as the treatment of obstructive sleep apnoea but can be used in the treatment of severe snoring (Littner, Kushida et al. 2001). 
1.3.5.4. Bariatric Surgery
NICE guidelines (2002) recommends bariatric surgery for patients with a BMI of >40 kg/m2 or in those with BMI 35-40kg/m2 with other significant medical diseases such as diabetes and hypertension. There are various bariatric surgical procedures such as gastric banding, gastroplasty, Roux-en-Y gastric bypass, bilio-pancreatic bypass and duodenal switch. Gastric banding and gastroplasty restrict food intake by reducing the size of stomach whereas other procedures induce weight loss by the combination of restricted intake and malabsorption. Buchwald et al (Buchwald, Avidor et al. 2004) reviewed 136 studies on the effect of bariatric surgery in 22,094 patients. The mean percentage of excess weight loss was 61.2% at 1 year. They also reported that obstructive sleep apnoea was resolved or improved in 83.6% of patients following bariatric surgery. Varela et al (Varela, Hinojosa et al. 2007) studied 56 morbidly obese patients with documented sleep apnoea who underwent Roux-en-Y gastric bypass surgery. They found that mean ESS score dropped from 13.7 (pre-operative) to 5.3 at one month post surgery and was maintained below 7 (normal) at 1 year. Moreover, only 14% of patients required CPAP at 3 months and none required CPAP at 9 months. These data were challenged by Lettieri et al (Lettieri, Eliasson et al. 2008) who studied the polysomnography data of 24 sleep apnoea patients before and 1 year after bariatric surgery. In spite of significant weight loss AHI only dropped from 47.9±33.8 to 24.5±18.1 events per hour. The required CPAP pressure dropped from 11.5±3.6 cm to 8.4±2.1 cm of water pressure. Only 1 patient (4%) experienced complete resolution of OSA at 1 year.                                                                                                                               
 
1.3.6. Pathophysiological effects of obstructive sleep apnoea and the effect of CPAP treatment
Obstructive sleep apnoea is known to be associated with cardiovascular diseases, stroke, pulmonary hypertension and the metabolic syndrome. Evidence supports long term CPAP treatment improving cardiovascular morbidity and mortality. The underlying mechanism by which this operates is still not fully understood. Different potential mechanisms are suggested such as oxidative stress (Lavie 2003), persistent sympathetic system over activation (Fletcher 2003) and increasing negative intrathoracic pressure generated during apnoeas affecting venous return (Bradley, Hall et al. 2001),(Shiomi, Guilleminault et al. 1991). 

1.3.6.1 Systemic Hypertension
In the normal population there is nocturnal ‘dipping’ of systolic and diastolic blood pressure (BP) during sleep (Staessen, Celis et al. 1991). Davies et al (Davies, Crosby et al. 2000) reported that, compared to normal controls, patients with sleep apnoea have significantly increased mean diastolic pressure during the  daytime and during the night. Higher systolic blood pressure was noted at night with blunting of the nocturnal dip in blood pressure. The Winconsin Sleep Cohort Study (Peppard, Young et al. 2000) analysed  blood pressure and AHI of 709 participants at baseline and after four years of follow-up. They found that the participants with sleep disordered breathing had higher rates of hypertension at the four year follow up  than controls, independent of other confounding factors such as BMI, age, sex, neck and waist circumference and smoking history.The cross-sectional analyses of 6120 participants in the Sleep Heart Health Study (Haas, Foster et al. 2005) found that sleep disordered breathing is associated with systolic/diastolic hypertension in those under 60 years of age. In an assessment of breath-by-breath blood pressure during apnoea, Lofaso et al (Lofaso, Goldenberg et al. 1998) found that blood pressure increased at the end of each apnoea.
Pepperell et al (Pepperell, Ramdassingh-Dow et al. 2002) studied ambulatory blood pressure after therapeutic and sub-therapeutic CPAP treatment in patients with sleep apnoea. They found that therapeutic CPAP reduced mean arterial ambulatory pressure by 2.5 mmHg. The benefit was larger in patients with more severe sleep apnoea. A meta-analysis of 12 placebo-controlled, randomised controlled trials showed a statistically significant reduction in mean BP of 1.69 mm Hg with CPAP treatment in patients with sleep disordered breathing (Haentjens, Van Meerhaeghe et al. 2007). Faccenda et al (Faccenda, Mackay et al. 2001) conducted a randomised placebo-controlled study assessing the effect of CPAP treatment on 24 hour blood pressure in normotensive sleep apnoea patients and found a small but statistically significant reduction in 24 hour diastolic blood pressure especially between 2:00 am and 9:59 am. The benefit was greater in those who used CPAP > 3.5 hr/night and those with a pre-treatment oxygen desaturation index of >20/hr. However, a multicenter randomised placebo-controlled, parallel-group study in 6 teaching hospitals in Spain (Barbe, Mayoralas et al. 2001)) reported that CPAP did not reduce arterial blood pressure in non-sleepy patients with a high AHI.
 1.3.6.2. Cardiac disease
Obstructive sleep apnoea is known to be associated with various forms of nocturnal cardiac dysrhythmia. The Sleep Heart Health Study showed that patients with severe OSAHS had a 2 to 4 time greater chance of arrhythmia including atrial fibrillation (AF), frequent ventricular ectopic beats or ventricular tachycardia after adjusting for confounders (Mehra, Benjamin et al. 2006). The retrospective cohort study of 3542 Olmsted County people (Gami, Hodge et al. 2007) also found that high BMI and nocturnal desaturation were independent risk factors for the incidence of nocturnal AF in subjects under 65 years of age.
Some epidemiological studies have shown the association between OSAHS and coronary artery disease. Hung et al (Hung, Whitford et al. 1990) conducted polysomnography in 101 survivors of acute myocardial infarction and control subjects without ischemic heart disease. They found that an AHI of greater than 5.3 was an independent predictor of myocardial infarction (relative risk of 23.3). A 7 year cohort study from a Swedish hospital clinic (Peker, Hedner et al. 2002) reported that the incidence of at least one cardio-vascular disease was 36.7% in patients with OSA compared to 6.6% in those without OSA. Moreover, effective treatment of OSA by CPAP or surgery was associated with a significant reduction in cardiovascular risk compared to incompletely treated cases. Marin et al (Marin, Carrizo et al. 2005) showed that untreated, severe OSAHS significantly increased the risk of fatal and non-fatal cardiovascular events. However, the Sleep Heart Health Study showed only a modest association between sleep apnoea and coronary heart disease (Shahar, Whitney et al. 2001).
There is increasing clinical evidence supporting the hypothesis that obstructive sleep apnoea and heart failure are closely linked. Sin et al (Sin, Fitzgerald et al. 1999) analysed 450 patients with congestive cardiac failure and found that men with a BMI >35kg/m2 are more prone to have OSA whereas the main risk factor for OSA in women with heart failure was age over 65. The Framingham Heart Study (Kenchaiah, Evans et al. 2002) also reported that obese individuals had a doubling of the risk of heart failure (the hazard ratio of 2.12 in females and 1.9 in males ). Therefore, high BMI may be the common risk factor for heart failure and obstructive sleep apnoea, rather than OSA leading to heart failure per se.
Kaneko et al (Kaneko, Floras et al. 2003) reported that one month of CPAP treatment in patients with co-existing OSA and heart failure improved left ventricular ejection fraction and reduced blood pressure. Mansfield et al (Mansfield, Gollogly et al. 2004) also reported significant improvements in left ventricular systolic function after 3 months of CPAP treatment in patients with OSA and mild-moderate heart failure. 

1.3.6.3. Cerebrovascular disease
Although many studies have investigated the association between stroke and obstructive sleep apnoea, it is still not clearly proven that OSA is an independent risk factor for stroke. Mohsenin et al (Mohsenin 2004) found that sleep apnoea occurred  in more than 50% of patients with acute stroke. They speculated that sleep apnoea may have been present before the stroke and that both conditions were associated with obesity, hypertension and coronary heart disease. In cross sectional analysis of the Winconsin Sleep Cohort study (Arzt, Young et al. 2005), those with an  AHI >20 had  an increased risk of stroke (odds ratio 4.3) and in prospective analysis, sleep apnoea patients with AHI>20 were more likely to suffer from first stroke within the following 4 years compared with those without sleep disordered breathing. The population based Sleep Heart Health Study also demonstrated that sleep disordered breathing is associated with self reported stroke (relative risk 1.58)(Shahar, Whitney et al. 2001). 

1.3.6.4. Pulmonary Hypertension
Some researchers speculate that daytime pulmonary hypertension and obstructive sleep apnoea may be closely linked due to nocturnal hypoxia, obesity related pulmonary dynamic functional changes and pulmonary vascular remodelling. Chaouat et al (Chaouat, Weitzenblum et al. 1996) studied 220 patients with an AHI>20 and found less than 20% of patients with OSA had daytime pulmonary hypertension (defined by mean pulmonary pressure of at least 20mmHg). This study also found that OSA patients with pulmonary hypertension were more obese, had lower partial pressure of arterial oxygen, had lower mean nocturnal arterial saturation and lower FEV1/FVC ratios than OSA patients without pulmonary hypertension. Coccagna et al also found sleep stage-dependent changes in pulmonary pressure more pronounced during rapid eye movement sleep (Coccagna, Mantovani et al. 1972). Sajkov et al (Sajkov, Wang et al. 2002) measured pulmonary hemodynamics in 20 patients with OSA before and after 4 months of CPAP therapy. CPAP therapy decreased pulmonary artery pressure by 2.9mmHg. Alchanatis et al (Alchanatis, Tourkohoriti et al. 2001) investigated 29 patients with OSA in the absence of heart and lung diseases and 12 control subjects. This study found a significantly higher mean pulmonary arterial pressure in those with OSA compared to controls. 6/29 OSA patients had mild pulmonary hypertension which partially or completely resolved with CPAP treatment. These six patients with pulmonary hypertension were older, had higher BMI and lower daytime oxygenation than pulmonary normotensive patients. 

1.3.6.5. Metabolic Syndrome, Diabetes and Insulin Resistance
Obstructive sleep apnoea is linked to the metabolic syndrome (also known as Syndrome X:  central obesity, hypertension, diabetes, hyperuricemia and dyslipidemia). The Mayo Clinic Sleep Disorder Centre (Parish, Adam et al. 2007) retrospectively studied 146 OSA patients and found 60% of these patients with the metabolic syndrome and hypertension. This study was unable to identify an independent association between OSA and metabolic syndrome in men younger than 50 and women of all age groups. The term Syndrome Z (the incorporation of sleep apnoea as well as Syndrome X) is being commonly used as these diseases are interrelated (Wilcox, McNamara et al. 1998). Coughlin et al (Coughlin, Mawdsley et al. 2004) demonstrated that subjects with sleep disordered breathing had higher blood pressure, higher fasting insulin (i.e. more insulin resistance), lower High Density Lipid (HDL) and increased incidence of the metabolic syndrome than controls (87% vs 35%, p<0.0001). Other researchers (Tauman, O'Brien et al. 2005; Sharma, Kumpawat et al. 2007) have not found an independent association between OSA and lipid abnormalities, insulin resistance, or serum leptin levels. These studies conclude that obesity, not OSA, is the main determinant factor for insulin resistance and type II diabetes.




1.3.6.6.	Psychosocial Consequences of Sleep Apnoea
Fragmented sleep due to sleep apnoea is associated with negative impacts on quality of life, the development of depression and adverse effects on work performance. Sleep disordered breathing can result in a negative impact on the quality of life of both patients and bed partners (Cartwright and Knight 1987; Briones, Adams et al. 1996; Ulfberg, Carter et al. 2000). Veale et al (Veale, Poussin et al. 2002) documented patients with sleep apnoea reporting depression, fatigue, sleepiness, snoring, nocturnal awakenings, obesity-related problems, relationship problem, poor memory and fear of dying. However, the perception of general health status was not related to the severity of respiratory events. Fornas et al (Fornas, Ballester et al. 1995) studied 103 sleep apnoea patients noting poor general health status scores that did not correlate with the number of the respiratory events per hour. 
Sleep apnoea also affects partners (Cartwright and Knight 1987; Ulfberg, Carter et al. 2000). Women living with heavy snorers reported disturbed sleep, morning headache, daytime sleepiness, more depression and socially isolation than divorced individuals. Treatment with CPAP has been found to improve quality of life in both patients and bed partners (D'Ambrosio, Bowman et al. 1999; McFadyen, Espie et al. 2001; Doherty, Kiely et al. 2003; Parish and Lyng 2003). 
CPAP improves perceived health status, fatigue and quality of life (Redline, Adams et al. 1998; Ballester, Badia et al. 1999; Engleman, Kingshott et al. 1999; Monasterio, Vidal et al. 2001). Engleman et al (Engleman, Martin et al. 1998) and Ballester et al (Ballester, Badia et al. 1999) conducted studies in patients with moderate to severe obstructive sleep apnoea and evaluated the effect of CPAP on daytime function, perceived health status and quality of life. Both studies found a significant improvement in perceived health status and sleep apnoea related symptoms compared to control groups who were treated with conservative therapy such as sleep hygiene and weight loss programmes. Redline et al (Redline, Adams et al. 1998) studied 171 subjects with mild obstructive sleep apnoea. 49% of patients treated with CPAP experienced a significant improvement in mood, energy/fatigue and functional status compared to the conservative therapy group. A similar result was found in a UK based randomized placebo-controlled study (Engleman, Kingshott et al. 1999).                                                                                                                             
The prevalence of depression is up to 50% in patients with obstructive sleep apnoea, and is more prevalent in females (Guilleminault, Eldridge et al. 1977; Reynolds, Kupfer et al. 1984; Kingshott, Vennelle et al. 2000; Akashiba, Kawahara et al. 2002). Depression was found to have a significant negative impact on quality of life independent of daytime sleepiness and the severity of nocturnal oxygen desaturation (Akashiba, Kawahara et al. 2002). Schwartz et al (Schwartz, Kohler et al. 2005) found 39% of patients had been prescribed  anti-depressant medications prior to referral to a sleep clinic. Some researchers feel that the incidence of depression is overestimated as fatigue and sleepiness are misinterpreted. Kingshott et al (Kingshott, Vennelle et al. 2000) and Schwartz et al (Schwartz and Karatinos 2007) report that depression symptoms improve with CPAP therapy. However, Munoz et al found that depression cannot be ameliorated by CPAP treatment in spite of good compliance with treatment (Munoz, Mayoralas et al. 2000). Further long term studies are required to clarify the association between depression, OSAHS and CPAP therapy.
Some patients with obstructive sleep apnoea report cognitive impairments such as poor thinking, memory, perception, attention, communication, planning, programming capacities, verbal fluency and learning ability (Naegele, Thouvard et al. 1995; Engleman, Kingshott et al. 2000). Naegele et al (Naegele, Thouvard et al. 1995) found that memory deficit was related to the number of apnoea and hyponoea events per hour and the level of nocturnal hypoxia. 76% of severe obstructive sleep apnoea patients are found to have a mild to moderate degree of cognitive impairment such as thinking, perception, memory, communication and the ability to learn new information (Kales, Caldwell et al. 1985). CPAP improves the levels of somnolence, vigilance (Munoz, Mayoralas et al. 2000), attention, learning and motor performance (Hack, Davies et al. 2000; Ferini-Strambi, Baietto et al. 2003). Munoz et al (Munoz, Mayoralas et al. 2000) found that CPAP treatment in patients with sleep apnoea significantly improved the level of somnolence and vigilance. Impaired vigilance may lead to an increased incidence of road traffic accidents. Hack et al (Hack, Davies et al. 2000) showed that therapeutic CPAP improved steering performance and reaction time to target stimuli compared to sub-therapeutic CPAP treatment.
Poor cognitive performance may have negative effects on work productivity. There are very limited studies about the relationship between work performance and sleep apnoea. A cross sectional population-based  study of Swedish men by Ulfberg et al (Ulfberg, Carter et al. 1996) found that the risk  for reporting excessive daytime sleepiness at work was 40 fold for patients with obstructive sleep apnoea compared to the general population. Patients with OSAHS reported difficulties with concentration, learning new tasks and performing monotonous tasks. Data analysed from the Swedish Obese Subjects (SOS) Study (Grunstein, Stenlof et al. 1995) reported that OSA was also an important independent predictor of incidence of increased sick leave days, worse self-rated general health and impaired work performance. Lavie et al (Lavie 1981) reported that workers with excessive daytime sleepiness were more prone to have work accidents and were less satisfied with their job. Moreover, the impact on employers in terms of the cost related to performance-based work loss, absenteeism and medical treatment was similar to that of other chronic illnesses (Goetzel, Long et al. 2004; Collins, Baase et al. 2005). Ulfberg et al (Ulfberg, Jonsson et al. 1999) reported significant improvement in work performance and a statistically significant decrease in work performance difficulties after treatment of OSA with CPAP.

1.3.6.7. Weight & Weight Reduction
Many researchers expect weight loss following CPAP treatment as reduction in daytime sleepiness and fatigue should increase motivation to lose weight and improve exercise capacity. Surprisingly some studies (Chin, Shimizu et al. 1999; Harsch, Konturek et al. 2003) report a significant increase in BMI in CPAP treated groups especially in adherent subjects. This may be biologically plausible as CPAP reduces blood leptin levels which may lead to increased calorie intake counteracting the beneficial effect of CPAP in somnolent patients (Stenlof, Grunstein et al. 1996; Marklund, Persson et al. 1998). 
Management of obesity consists of modification of diet, increased physical activity and surgery. Dietary therapy initiated by a nutritionist to reduce weight should be implemented in most patients. The American College of Sports Medicine (ACSM) (Jakicic, Clark et al. 2001) recommends the combination of reduced calorie intake and increased energy expenditure with structured exercise and physical activity. They recommend an energy deficit of 500-1000Kcal/day and reduction of total fat intake to less than 30% to facilitate weight loss. Behaviour therapy, including individual or group counselling to eliminate unhealthy eating behaviours, is a useful adjuvant treatment for weight loss.                                                                                                              
Exercise therapy is crucial to weight loss and maintains weight loss in the obese sleep apnoea patients. ACSM (Jakicic, Clark et al. 2001) recommends a minimum of 150 min (2.5hr) of moderate intensity exercise per week which should progressively increase to 200-300min (3-3.5hr) per week to facilitate the long term maintenance of weight loss. A meta-analysis by Miller et al (Miller, Koceja et al. 1997) showed that weight loss through a 15-week diet or diet plus exercise program is about 11kg. In a one year follow-up, diet plus exercise tended to have maintained weight loss more efficiently than diet alone.       

1.3.7. Obstructive Sleep Apnoea and Exercise
The treatment of obstructive sleep apnoea should aim to improve life style by encouraging weight loss and increasing physical activity. Some studies indicate that weight reduction by diet and exercise can reduce the severity of obstructive sleep apnoea (Noseda, Kempenaers et al. 1996; Kajaste, Brander et al. 2004; Peppard and Young 2004). However, patients with obstructive sleep apnoea have a reduced exercise capacity compared with non-OSA controls (Vanuxem, Badier et al. 1997; Grote, Hedner et al. 2004; Guillermo, Gal et al. 2006; Lin, Hsieh et al. 2006). Lin et al (Lin, Hsieh et al. 2006) tested  patients with moderate or severe OSAS and matched controls using cardiopulmonary exercise testing. They showed that the patients with obstructive sleep apnoea had a lower VO2max (the maximum oxygen consumption by working muscle) than controls. Grote et al (Grote, Hedner et al. 2004) demonstrated that maximum exercise capacity tended to decrease with severity of obstructive sleep apnoea and also found patients to display a blunted heart rate response to exercise. A retrospective control study by Guillermo et al (Guillermo, Gal et al. 2006)  also showed that patients with an AHI greater than 20 have a statistically significant reduction in aerobic fitness compared to normal population. 
Cardiovascular system is vital to deliver oxygen to active skeletal muscle and the pulmonary circulation during exercise (Dowell 1983). As exercise intensity increases, heart rate and stroke volume (the amount of blood ejected with each heart contraction) increases resulting in increasing cardiac output (Rowell 1974). Some studies suggest that obstructive sleep apnoea is linked to cardiac dysfunction (Alonso-Fernandez, Garcia-Rio et al. 2006; Otto, Belohlavek et al. 2007). A prospective, randomised, double-blind, placebo-controlled cross-over clinical trial by Alonso-Fernandez et al (Alonso-Fernandez, Garcia-Rio et al. 2006) evaluated cardiac responses to exercise in middle-aged normotensive adults with obstructive sleep apnoea with normal resting left ventricular function. They showed that OSAHS subjects had a lower cardiac output and stroke volume in response to exercise than healthy subjects. Otto et al (Otto, Belohlavek et al. 2007) reported that obese patients with obstructive sleep apnoea had an increased ventricular afterload as a result of large negative intrathoracic pressure swings during apnoeas. The pathogenesis of impaired cardiac dysfunction is still under debate. Repeated upper airway closure usually leads to intermittent hypoxia and hypercapnia. Subsequently this stimulates sympathetic nervous system activity resulting in desensitization of cardiac receptors (Kaleth, Chittenden et al. 2007) and decreasing cardiac output and stroke volume to exercise. This hypothesis is supported by various studies (Ferrier, Campbell et al. 2005; Alonso-Fernandez, Garcia-Rio et al. 2006; Lam, Yan et al. 2009) that found that patients with obstructive sleep apnoea had increased nocturnal catecholamine levels compared to healthy subjects. Impaired cardiac dysfunction may also be due to co-existing insulin resistance (Punjabi, Ahmed et al. 2003) and hypertension (Bradley and Floras 2009) in patients with OSA.
The respiratory system is another essential organ for delivering oxygen to exercising muscle and eliminating waste products during exercise. At lower exercise intensity, ventilation is accompanied by increases in tidal volume (the amount of air in and out of the lung during regular breathing).This increased ventilation delivers efficient gas exchange in the lungs. As exercise progresses and muscle generates more metabolites such as carbon dioxide and hydrogen ions these metabolites stimulate peripheral and central (brain) chemoreceptors resulting in increasing depth and rate of respiration. In these ways, the respiratory system is regulated to meet the increasing metabolic demand to maximize exercise performance during exercise. 
The majority of OSAHS patients are obese. Central obesity may have an important role in impairment of respiratory function. Obesity affects dynamic lung volumes. A restrictive pattern of spirometry is common in morbidly obese individuals (Rubinstein, Zamel et al. 1990) with central fat deposition (Canoy, Luben et al. 2004). This pattern of spirometric abnormality results from greater reductions in forced vital capacity (FVC) as compared to forced expiratory volumes in 1 second (FEV1). This FVC reduction is reflective of reduced global lung volumes secondary to obesity. The EPIC-Norfolk population based cohort study found that forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) were inversely related to waist and hip ratio in both sexes (Canoy, Luben et al. 2004). Dyspnoea in these patients may be due to poor lung compliance and respiratory muscular fatigue. Obese people have reduced chest wall compliance and lower operating lung volumes such as reduced tidal volume, total lung capacity (TLC), vital capacity (VC) (Rubinstein, Zamel et al. 1990), sitting expiratory reserve volume (ERV) and functional residual capacity (FRC) which are further reduced in the supine position due to the gravitational effects of large abdomen (Chinn, Cotes et al. 1996; Despres, Lemieux et al. 2001; Koenig 2001). Moreover, some studies (Sharp, Henry et al. 1964; Weiner, Waizman et al. 1998) suggest that respiratory muscle weakness may also occur. 
Some authors hypothesise that alterations in metabolism and structure of muscle may contribute the impaired exercise capacity. During exercise, active skeletal muscle requires increased blood flow. This need is met through increased sympathetic stimulation to vasodilator fibres in skeletal muscle and decreased parasympathetic stimulation to vasoconstrictors fibres (Laughlin and Armstrong 1985). Some researchers suggest that impaired endothelial dependent vasodilatation in patients with obstructive sleep apnoea may be responsible for impaired exercise tolerance (Carlson, Rangemark et al. 1996; Kraiczi, Caidahl et al. 2001; Ohike, Kozaki et al. 2005). Endothelium derived nitric oxide (EDNO) production regulates blood flow in limbs during exercise (Jin, Wong et al. 2005). Increased blood flow during exercise generates sheer stresses on endothelial cells which produce EDNO resulting in vasodilatation. Conditions that cause reduced EDNO production can disturb the hyperaemic response to exercise resulting in  reduced exercise capacity (Maxwell, Schauble et al. 1998). Repeated attacks of hypoxia might be related to depressed NO production as oxygen is a co-substrate of NO synthase (Ozkan, Firat et al. 2008). 
As well as exogenous inhibition, patients with obstructive sleep apnoea have an endogenous inhibition of endothelial nitric oxide synthesis (Ohike, Kozaki et al. 2005).  Carlson et al (Carlson, Rangemark et al. 1996) and Kraiczi et al (Kraiczi, Caidahl et al. 2001) demonstrate that endothelium-dependent vascular relaxation is reduced in patients with obstructive sleep apnoea, a phenomenon related to the severity of apnoea- related hypoxemia (Kraiczi, Caidahl et al. 2001). 
Normally neural receptors in skeletal muscle are very sensitive and responsible to increased sympathetic outflow during exercise to produce vasoconstriction of non-exercising vascular beds (Piepoli, Clark et al. 1996). Patients with obstructive sleep apnoea have sympathetic over-activity (Somers, Dyken et al. 1995; Fletcher 2003) which may blunt the sensitivity of neural receptors in muscle. 
Reduced exercise capacity in sleep apnoea patients may be due to impairment of muscular metabolism. The predominant energy substrate for exercising skeletal muscle is glucose and free fatty acid. For our body to meet high energy demands imposed by exercise more glucose must be available to muscle. Muscle glucose is derived from blood glucose and follows breakdown of glycogen stores in muscle and liver. Insulin stimulates the transport of glucose from the blood stream into skeletal muscle via insulin-regulated glucose transporters. Obstructive sleep apnoea is known to be associated with insulin resistance (Wilcox, McNamara et al. 1998; Ip, Lam et al. 2002; Punjabi, Sorkin et al. 2002). Thus impaired glucose transport to skeletal muscle may result.
Aerobic energy metabolism (energy production in the presence of oxygen) is the primary form of energy production for the body. With fast movement during exercise anaerobic metabolism (energy production in the absence of oxygen) becomes predominant. This anaerobic glycolysis generates lactic acid. Excessive accumulation of lactic acid can impair glycolytic (glucose breakdown) enzyme function thus impairing delivery of substrate to muscle. Chronic hypoxia, in conditions such as emphysema for example, is known to be associated with reduced muscular mass and mitochondrial volume density (Cerretelli 1992) resulting in reduced oxidative metabolism, activating anaerobic metabolism and leading to lactic acidosis. Vanuxem et al (Vanuxem, Badier et al. 1997) demonstrated reduced muscular metabolism resulting in lower lactate elimination rates in patients with obstructive sleep apnoea. Bonanni et al (Bonanni, Pasquali et al. 2004) found that patients with obstructive sleep apnoea had significantly higher exercise lactate levels and earlier lactate thresholds than normal controls. Lactic acidosis decreases the muscular fibres’ calcium-binding capacity. As calcium is an essential ion responsible for muscle contraction deficits in calcium ion binding may impair muscular contraction during exercise. 
Lack of regular exercise in sleep apnoea may be simply due to excessive daytime sleepiness (EDS). Data from the National Sleep Foundation’s Sleep in Americans poll found that daytime sleepiness is associated with decreased exercise capacity after controlling for BMI, age, income and co-morbidity (Chasens, Sereika et al. 2007). Basta et al (Basta, Lin et al. 2008) evaluated the relationship between EDS and exercise performance in 1160 patients with sleep apnoea and found that lack of exercise is significantly associated with daytime sleepiness in both sexes. Sleep fragmentation in patients with obstructive sleep apnoea can lead to sedentary living (Smith, Doyle et al. 2007), lack of motivation and deconditioning which may be the major contributing factor to reduced exercise capacity. CPAP is proven to improve excessive daytime sleepiness (Jenkinson, Stradling et al. 1997; Engleman, Martin et al. 1998; Ballester, Badia et al. 1999; Hack, Davies et al. 2000; Monasterio, Vidal et al. 2001). CPAP also improves left ventricular function and cardiac output (Mansfield, Gollogly et al. 2004) by various mechanisms such as abolishment of apnoea-related hypoxia (Kaneko, Floras et al. 2003), decreases in systolic blood pressure (Mansfield, Gollogly et al. 2004), decreases in sympathetic tone (Mansfield, Gollogly et al. 2004) and decreases in left ventricular afterload (Naughton, Rahman et al. 1995). Moreover, CPAP improves endothelial function by potentiating NO production which is essential for the vasodilatatory response of skeletal muscle during exercise (Ohike, Kozaki et al. 2005). 






There is limited data regarding impairment of exercise capacity in patients with obstructive sleep apnoea and the effect of CPAP on exercise ability (Alonso-Fernandez, Garcia-Rio et al. 2006; Schlosser, Walther et al. 2006). Despite this physical activity is supported in many guidelines as a part of the long term management of patients with obstructive sleep apnoea (Taguchi, Hida et al. 1997). Moreover, the mechanism of assessment of exercise capacity using exercise tests warrants further studies, as many techniques of assessment recorded in the literature (Keell, Chambers et al. 1998; Morales, Martinez et al. 1999; Fearon, Gauri et al. 2002) require well equipped laboratories making monitoring of exercise capacity in clinical services challenging. The characterisation of a simple, reproducible assessment tool would allow the identification of patients at high risk of cardiopulmonary morbidity allow the monitoring of the effect of treatment.  Additionally these simple monitors may be useful in clinical rehabilitation programmes for patients with OSA. 







(1) To assess the utility of ISWT to measure change in physical function in patients with OSAHS following CPAP therapy.

(2)To assess effects of CPAP on cardio-pulmonary responses during the incremental shuttle walk test in patients with obstructive sleep apnoea.

(3) To determine the effect of change in physical function on quality of life in patients with OSAHS on CPAP therapy.









Study subjects were recruited from referrals to the sleep service in Sheffield Teaching Hospitals. Patients eligible for the study were those with a confirmed diagnosis of obstructive sleep apnoea with:  
-	More than 10 oxygen desaturation events of greater than 4% per hour as recorded by overnight pulse oximetry (ODI>10)	 or
-	An Apnoea-Hyponoea Index (AHI) of more than 15 on polysomnography (moderate to severe OSAHS severity)      and                 
-	Excessive Daytime somnolence as defined as an Epworth Sleepiness Scale score of more than 11.                                                               
       
Patients excluded from study were those with:
1.	Sleep disorders other than obstructive sleep apnoea 
2.	Significant  co-morbidities (unstable ischemic heart disease with angina at rest or minimal exertion or neuromuscular disease affecting respiratory muscles),
3.	Previous treatment with CPAP for OSAHS




The study was designed as a prospective observational study. After providing informed consent each subject received a primary health interview including a full medical history specifically documenting the presence (or absence) of hypertension, diabetes, hypercholesterolemia, angina or stroke. All participants underwent ECG (electrocardiogram) and spirometry as a part of initial assessment. Participants were invited to complete a series of questionnaires including Epworth Sleepiness Scale, the SF-36 quality of life questionnaire and the General Practitioners Activity questionnaire (GPAQ). All subjects underwent incremental shuttle test and completed relevant questionnaires prior to being provided with CPAP (REM star Pro M, Model 401M, Respironics, UK). Subjects were given expert advice regarding effective CPAP utilisation. Subjects were reviewed and reassessed at 2 weeks. CPAP compliance hours were downloaded from smart card inserted in the CPAP machine. Those who were CPAP compliant (i.e. those having utilised CPAP for at least 4 hours per night) were invited to perform repeat assessment at that time and then again at 3 and 6 months following CPAP initiation (irrespective of CPAP compliance at those time points; CPAP-C group). Subjects who were not attaining these levels of compliance with therapy at 2 weeks, but who were willing to persevere with treatment, were also invited to conduct assessments at these time points (CPAP-PC; partially compliant group). Participants unable to tolerate CPAP were invited to complete a single assessment 6 months after their initial visit (CPAP-I; intolerant group).

4.1.1. Incremental Shuttle Walk Test





The primary outcome of the test is the distance walked in meters. Throughout the test, the subjects wore a pulse oximeter (Minolta Pulsox 3i, Minolta Co Ltd, Japan) which recorded heart rate and oxygen saturation. Blood pressure was measured before testing using a digital automated arm blood pressure machine (Omron Digital Automatic Blood Pressure Monitor Omron 705IT, Omron Matsusaka Co Ltd, Japan). Resting blood pressure, blood pressure at 1 and 2 minutes post-exercise were measured. The subjective sensation of breathless was measured using the BORG breathless scale (Appendix 5) (Burkhalter 1996) before and immediately after exercise. Age-predicted maximum heart rate was calculated by the following validated equation: (220-Age in years). For assessment of chronotropic response, peak heart rate was expressed as percent of age predicted heart rate. The percentage of heart rate reserve was calculated as (peak heart rate-heart rate at rest)/ (age predicted heart rate – heart rate at rest) x 100 (Lauer, Okin et al. 1996; Lauer, Francis et al. 1999). Chronotropic incompetence was defined as failure to achieve 85% of the age predicted maximum heart rate and failure to achieve heart rate reserve of 80% (Lauer, Francis et al. 1999).
Heart rate recovery was defined as the difference between maximum heart rate and 1 minute after recovery (heart rate recovery at 1 minute) (HRR-1) and 2 min of recovery (heart rate recovery at 2 min)(HRR-2) respectively (Shetler, Marcus et al. 2001). 
Cardio-respiratory fitness (CRF) was measured by estimating VO2max calculated using the equation (Singh, Morgan et al. 1994): (4.19 + 0.025 x walking distance)x body weight (ml/min).  A VO2max value of <19.9ml/kg/min is considered as ‘poor’, 20-27.9ml/kg/min as ‘fair’ and >30 as ‘good’ according to the classification of CRF by McArdle et al (McArdle, Katch et al. 1991).

4.1.2. Anthropometric measurements







4.1.3.1 The Epworth Sleepiness Scale (ESS)
The Epworth Sleepiness Scale (ESS) is a validated questionnaire which assesses subjective sleepiness in 8 specific daily situations. Each domain is scored from 0-3 dependent on the likelihood of an individual dozing in each given circumstance. The sum of each domain encompasses the total score ranging from 0 to 24. A score of more than 10 indicates that the person suffers from pathological daytime sleepiness (Appendix 1). 
 
4.1.3.2 The Hospital Anxiety Depression Scale (HADS)
The HADS (Appendix 6) is a 14 items (7 items for depression and 7 items for anxiety) self-rated questionnaire used to measure depression and anxiety during the last seven days. Each item has a range of 0-3 and therefore the possible total score ranges from 0 to 21 for anxiety and 0-21 for depression. A score of 0 to 7 is regarded as being in normal range; a score of 8 to 10 suggests a possible mood disorder and a score of 11 or higher is suggestive of a probable mood disorder. HADS has been used to monitor psychometrics in patients with a variety of chronic illnesses (Zigmond and Snaith 1983; Herrmann 1997; Baldacchino, Bowman et al. 2002).
4.1.3.3 The SF-36 (short form 36)
SF-36 (Appendix 7) is a 36-item questionnaire which measures 8 domains of health: physical functioning (limitation in physical activity because of health problems), physical problems (limitation in role activities because of physical health problem), emotional problems (limitation in usual role activities due to emotional problems), social functioning (limitation in social activities because of physical and emotional problems), mental health, vitality (energy and fatigue), pain and general perception of health (Tarlov, Ware et al. 1989; Ware and Sherbourne 1992). Each domain scores from a range of 0 to 100 with a score of zero reflecting worst health and 100 best health. SF-36 is widely used as the assessment tool for quality of life in  sleep disordered breathing studies and has been found to be highly reliable, valid and responsive in monitoring the effect of the disease and treatment (Jenkinson, Stradling et al. 1997).

4.1.3.4 General Practice Physical Activity Questionnaire










5.1. Study Population 
Recruitment took place between August 2009 and June 2010. 41 willing subjects fulfilled the inclusion criteria. 4 patients declined to participate in the study for personal reasons. 
Table 2 shows baseline characteristics. The subjects are predominantly middle aged males with high BMI (>30kg/m2). No statistical differences were observed between the 3 groups other than that the patients in the CPAP-I group had statistically lower oxygen desaturation indices (ODI) compared with CPAP tolerant patients.
In addition there was a trend for the CPAP-I to have a better quality of life (with a lower HAD depression score and higher SF36 QOL domain scores (Table 3).  Frequency of exercise was not significantly different between groups. All patients tolerated the ISWT well and no adverse events were reported during the tests. The mean ISWT distance and calculated VO2max were not significantly different between groups (Tables 4).

5.2. Long-term usage of CPAP
Compliance with CPAP therapy remained constant throughout the 6 month period. Mean CPAP compliance in the CPAP-C group was 5.2±0.3, 5.1±0.3 and 5.7±0.3 hours per night at 2, 12 and 26 weeks respectively, and 3.0±0.4, 2.5±0.3 and 2.4±0.3 hours per night at 2, 12 and 26 weeks respectively in the CPAP-PC. 

5.3. Effect of CPAP on ISWT performance
Following the introduction of therapy CPAP-C subjects increased walking distances within 2 weeks and maintained/increased exercise performance over the 26 week period (410.00+/-197.24 meter at baseline vs. 517.73+/-260.26 meter at 26 weeks,p<0.001) (Table 5). No significant change in walking distance was noted both in CPAP-PC group and CPAP-I group over the 6 month assessment period. No significant increase in maximal BORG score was identified in any group. Changes in calculated VO2max reflected changes in walking distance. 



















Baseline ODI (>4%/hr)	31.5 (6.2)	31.1 (7.2)	16.5 (5.8)*
Age (yrs)	50.5 (2.0)	 52.3 (2.9)	54.4 (2.5)
Sex (M:F)	15:6	7:2	7:0
Height (m)	1.74 (0.02)	1.74 (0.04)	1.78 (0.01)
Weight (kg)	108.7 (5.9)	109.0 (4.8)	109.9 (9.5)
BMI (kg/m2)	36.0 (2.0)	37.0 (3.3)	34.9 (3.2)
Neck circumference (cm)	44.7 (1.2)	43.9 (0.8)	46.2 (1.1)
Waist circumference (cm)	118.0 (4.4)	115.9 (6.1)	120.5 (7.3)
Hip circumference (cm)	120.1 (3.7)	121.4 (5.7)	116.1 (4.5)
Waist:Hip ratio	0.98 (0.02)	0.95 (0.02)	1.03 (0.03)
Systolic BP	141.7 (4.3)	148.6 (7.6)	140.7 (6.5)
Diastolic BP	82.9 (2.7)	85.3 (1.3)	86.6 (2.7)
FVC (% predicted)	89.2 (3.9)	89.1 (6.1)	102.9 (7.4)
Comorbid illness			
Hypertension 	9 (43%)	4 (44%)	3 (43%)
Stroke/CVD 	2 (10%)	0 (0%)	1 (14%)
Diabetes (Type 2)	6 (29%)	3 (33%)	1 (14%)
IHD	1 (5%)	1 (11%)	2 (28%)





















Table 2. Demographic, anthropomorphic and physiological characteristics for all patient groups at initial assessment. Values are expressed as mean (SE) or absolute number (%). 





ESS	15.5 (0.7)	14.3 (0.9)	12.9 (1.6)
HAD 			
HAD-Anxiety           	8.0 (1.0)	7.1 (1.5)	7.1 (1.2)
HAD-Depression	8.0 (0.8)	6.9 (1.6)	5.3 (0.9)*
SF36 			
Physical Function	57.6 (5.8)	68.8 (10.6)	77.0 (14.5)
Physical problem	51.2 (8.4)	43.8 (16.9)	75.0 (13.7)**
Emotional problem	54.0 (9.6)	50.0 (18.9)	93.3 (6.7)+
Social Function	61.9 (6.4)	54.2 (12.2)	88.9 (11.1)++
Mental health	56.4 (5.4)	60.5 (7.5)	72.8 (10.2)
Energy & Vitality	31.2 (5.0)	31.1 (5.3)	53.0 (13.6)
Pain	61.4 (5.7)	56.9 (12.0)	75.6 (9.6)
Perception of Health	38.1 (5.1)	46.9 (7.6)	66.8 (15.0)
Change in health	39.3 (4.7)	34.4 (6.6)	45.0 (12.2)
GP Activity			
PAI	2.2 (0.3)	1.9 (0.4)	2.2 (0.4)
Exercise hours/day	4.3 (0.4)	4.5 (0.5)	4.6 (1.3)














Table 3.  Baseline questionnaire scores. Values are expressed as mean (SE). 

*CPAP-C versus CPAP-I p=0.044  
** CPAP-PC versus CPAP-I p=0.037 
+CPAP-PC versus CPAP-I p=0.020 







ISWT distance (m)	407.1 (44.0)	391.1 (66.6)	522.9 (87.7)
Maximum BORG score	3.6 (0.3)	2.9 (0.3)	2.6 (0.6)
Calculated VO2max (ml/min)	1551.7 (114.6)	1479.5 (152.1)	1834.4 (200.3)
Resting heart rate (bpm)	78.6 (3.4)	75.7 (4.8)	80.6 (5.7)
Maximum heart rate (bpm)	128.3 (6.0)	112.9 (4.6)	133.3 (9.2)*
Heart rate recovery 2 min (bpm)	-38.0 (3.7)	-32.8 (5.9)	-40.0 (5.5)
Maximum SBP (mmHg)	163.0 (6.0)	167.8 (7.5)	163.6 (12.7)
Maximum DBP (mmHg)	85.3 (2.3)	93.7 (4.2)	88.7 (6.1)


Table 4. Baseline incremental shuttle walk data. Values are expressed as mean (SE). 

*CPAP-C versus CPAP-I p=0.011; CPAP-PC versus CPAP-I p=0.024.


 No change in resting heart rate was noted in any group throughout the study. Statistically significant increases in peak heart rate were noted in the CPAP-C (128.36+/-26.99mmHg at baseline vs. 169.09+/-9.41 mmHg at 26 weeks, p<0.001) and CPAP-PC groups at 26 weeks (112.89+/-13.91mmHg at baseline vs. 167.67+/-8.83 mmHg at 26 weeks, p<0.001) More rapid recovery from peak heart rate following cessation of exercise was also noted in the CPAP-C group (Heart Rate Recovery at 2 min post-exercise; 38.46+/-16.64 beats/min at baseline vs. 46.50+/-12.18 mmHg, p=0.03) (Table 8). 

 5.4. Impact of CPAP on frequency of exercise 
There were statistically significant, improvements in both the number of hours of activity conducted each day and the amount of strenuous activity conducted each week in the CPAP-C group. A significant improvement was also found in the number of exercise days per week assessment for the CPAP-PC group at 2 and 26 weeks respectively; (P=0.051 at 12 weeks). No modification to exercise behaviour was identified in the CPAP-I group over the course of the study (Table 9).

5.5. Effect of CPAP on anthropometrics 
CPAP therapy resulted in no statistically significant change in weight, BMI or neck circumference. Waist and hip circumferences were significantly reduced in CPAP compliance group and CPAP intolerant group at 26 weeks.  

5.6. Effect of CPAP on symptoms of daytime sleepiness and quality of life 
Following the introduction of CPAP symptoms of daytime sleepiness improved in both CPAP-C and CPAP-PC groups, with values falling within 2 weeks of treatment into the normal range (<11). The effect, which was highly statistically significant, persisted for the duration of the study in both groups. A lesser magnitude of change was seen in the CPAP-PC group as compared with the CPAP-C (mean change in ESS (se) -3.7 (0.9), -3.4 (1.4), -5.0 (1.1) versus -4.2 (1.3), -6.6 (1.4), -7.9 (1.3) at 2, 12 and 26 weeks respectively; Table 11).














	                         CPAP-C  (n=21)	                       CPAP-PC  (n=9)	                  CPAP-I (n=7)
	Baseline	2 weeks	12 weeks	26 weeks	p 	Baseline	2 weeks	12 weeks	26 weeks	P	Baseline	26 weeks	P










		                   CPAP- C (n=21)	              CPAP-PC (n=9)	CPAP-I (n=7)
	Baseline	2 weeks	12     weeks	26    weeks	p         	Baseline	2   weeks	12    weeks	26   weeks	p        	Baseline	26  weeks	p        
Resting SBP (mmHg)Mean(SD)	143.14(20.34)	143.09(22.17)	134.14(17.70)	136.86(16.44)	0.03	148.56(22.77)	148.44(16.39)	150.22(16.61)	145.67(11.37)	0.93	142.67(15.01)	143.58(18.02)	0.84
Resting DBP  (mmHg)Mean(SD)	83.36(12.29)	80.99(12.41)	77.50(13.64)	76.41(11.57)	0.02	85.33(4.00)	85.56(12.91)	81.89(12.58)	80.11(14.05)	0.38	83.33(9.10)	81.83(7.79)	0.60
Post-exercise SBP (mmHg)Mean(SD)	165.31(29.18)	173.68(31.56)	162.27(27.81)	163.86(26.44)	0.22	167.78(22.46)	170.33(31.66)	179.11(18.24)	181.33(21.87)	0.58	168.33(28.81)	163.75(29.35)	0.55
Post-exercise DBP (mmHg)Mean(SD)	85.50(10.15)	85.81(12.03)	83.36(12.35)	82.77(10.23)	0.48	93.67(12.49)	86.78(12.09)	88.11(10.47)	83.77(17.05)	0.14	84.92(14.53)	84.00(12.11)	0.79
3 min Post-exercise SBP(mmHg)Mean(SD)	147.04(22.32)	155.86(27.24)	148.09(21.27)	147.00(19.34)	0.52	151.22(28.88)	153.67(22.21)	155.89(12.93)	153.56(16.45)	0.96	148.17(14.41)	146.00(15.83)	0.64
3 min Post-exercise DBP(mmHg)Mean(SD)	84.91(8.97)	82.77(12.77)	79.77(11.08)	79.05(9.06)	0.04	93.78(13.76)	84.44(9.67)	85.78(12.13)	85.89(15.31)	0.12	83.33(13.28)	82.58(8.26)	0.82











Figure 5; Changes in systolic and diastolic pressure among groups  
          

                             Figure 6; Heart rate during incremental shuttle walk test.                                 

		                   CPAP- C (n=21)	              CPAP-PC (n=9)	CPAP-I (n=7)
	Baseline	2 weeks	12     weeks	26    weeks	p         	Baseline	2   weeks	12    weeks	26   weeks	p         	Baseline	26  weeks	p        
Resting Heart Rate(Beats/min)Mean (SD)	75.31(23.21)	74.86(22.34)	80.23(13.81)	74.31(12.33)	0.61	65.67(28.37)	78.00(11.63)	77.44(9.48)	76.78(9.76)	0.64(6.00)	56.58(36.74)	73.50(10.02)	0.10
Maximum Heart rate achieved during exercise(beats/min)Mean(SD)	128.36(26.99)	139.05(26.14)	136.14(23.20)	169.09(9.41)	<0.001	112.89(13.91)	125.33(19.97)	129.44(18.92)	167.67(8.83)	<0.001	127.58(19.75)	126.75(18,28)	0.88
Age predicted maximum HR (%)Mean(SD)	75.75(14.37)	82.00(13.25)	80.44(12.59)	80.52(12.90)	0.05	67.40(8.14)	74.66(10.18)	77.44(12.14)	73.80(11.40)	0.11	77.03(11.08)	76.47(8.23)	0.86
Heart Rate Recovery at 1 min post-exercise(HRR-1)(Max HR minus HR 1 min Post-Ex) Beats/min Mean (SD)	30.27(16.75)	36.59(10.19)	33.82(13.64)	31.00(11.06)	0.24	28.56(20.16)	33.00(18.76)	32.11(18.57)	26.33(13.88)	0.76	36.42(19.63)	32.92(12.93)	0.57
Heart Rate Recovery at 2 min post-exercise(HRR-2)(Max HR minus HR 2 min Post-Ex) Beats/min Mean (SD)	38.46(16.64)	48.18(12.16)	43.82(12.48)	46.50(12.18)	0.03	32.78(17.83)	42.33(18.75)	42.67(16.66)	39.78(16.42)	0.29	42.67(12.05)	41.92(13.59)	0.87
Table 7: Resting HR, Maximum HR achieved during exercise, Age Predicted Max HR, Heart Rate Recovery at 1 min (HRR-1) and Heart Rate Recovery at 2 min (HRR-2). Statistically significant data are highlighted with bold. Significant changes in Max HR, Age predicted max HR and HRR-2 noted only in CPAP-C group.                                                                                                         


		                   CPAP- C (n=21)	              CPAP-PC (n=9)	CPAP-I (n=7)
	Baseline	2 weeks	12     weeks	26    weeks	p         	Baseline	2   weeks	12    weeks	26   weeks	p         	Baseline	26  weeks	p        
Physical Activity Index(PAI)Mean (SD)	2.19(1.25)	2.10(1.51)	2.10(1.41)	2.24(1.34)	0.94	1.67(1.12)	1.44(1.01)	1.67(0.87)	1.89(1.17)	0.29	1.67(1.44)	1.75(1.48)	0.75
Hours of Exercise per dayMean (SD)	4.33(2.05)	5.00(2.88)	5.90(2.53)	6.95(2.25)	0.001	4.00(3.20)	4.33(2.87)	4.56(1.51)	5.67(2.29)	0.14	3.92(3.90)	5.00(4.92)	0.31
Days of Exercise per weekMean (SD)	0.95(1.47)	2.19(2.14)	3.10(2.14)	2.81(1.78)	<0.001	1.00(1.12)	2.22(1.99)	3.22(2.54)	2.67(1.58)	0.01	1.75(2.26)	1.17(1.34)	0.38











		                   CPAP- C (n=21)	              CPAP-PC (n=9)	CPAP-I (n=7)
	Baseline	2 weeks	12     weeks	26    weeks	p         	Baseline	2   weeks	12    weeks	26   weeks	p         	Baseline	26  weeks	p        
Body Mass Index(BMI)(kg/m2)Mean (SD)	36.03(8.96)	35.87(8.81)	35.41(8.04)	35.13(7.23)	0.06	36.98(9.92)	36.72(8.84)	36.78(8.33)	36.87(8.14)	0.95	34.81(6.51)	35.88(6.11)	0.19
Neck circumference(cm)Mean (SD)	44.90(5.39)	44.70(5.25)	43.84(5.47)	43.89(5.14)	0.03	36.98(9.92)	43.44(2.31)	43.33(2.87)	43.50(2.36)	0.02	45.88(2.71)	45.88(3.43)	1.00
Waist and Hip RatioMean (SD)	0.99(0.10)	0.99(0.09)	0.98(0.10)	0.96(0.09)	0.16	0.95(0.06)	0.97(0.05)	0.98(0.06)	0.97(0.05)	0.68	1.05(0.06)	1.04(0.06)	0.26












		                   CPAP- C (n=21)	              CPAP-PC (n=9)	CPAP-I (n=7)
	Baseline	2 weeks	12     weeks	26    weeks	p         	Baseline	2   weeks	12    weeks	26   weeks	p         	Baseline	26  weeks	p        
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This study is the first to demonstrate the utility of the incremental shuttle walk test to assess the exercise capacity in patients with obstructive sleep apnoea. The objective measurement of exercise capacity is widely used in many diseases to assess functional capacity (Keell, Chambers et al. 1998; Morales, Martinez et al. 1999; Fearon, Gauri et al. 2002), to measure the therapeutic effect of drugs and  to evaluate the outcome of cardiopulmonary rehabilitation (Evans, Singh et al. 2009). Exercise tests vary from laboratory based cardio-pulmonary exercise tests (treadmill test, cycle ergometry test) to simple field tests (six minute walk test, incremental shuttle walk test, endurance shuttle walk test). The cardio-pulmonary exercise test is a reliable and valid test to measure functional capacity in terms of peak oxygen consumption in chronic respiratory and heart diseases (Mancini, Eisen et al. 1991). It is, however, time consuming and expensive as it requires advanced technical equipment and trained exercise physiologists to be conducted. Alternatively field exercise tests and programmed exercise tests can be performed. These have been shown to correlate well with the cardiopulmonary exercise test (Singh, Morgan et al. 1994; Casas, Vilaro et al. 2005; Pulz, Diniz et al. 2008). The 6 minute walk test is widely used as it is simple and relevant to daily life. However, it is self-limited and self-paced. In contrast the ISWT is a progressive, externally paced test. Several studies (Singh, Morgan et al. 1992; Keell, Chambers et al. 1998; Morales, Martinez et al. 1999; Morales, Montemayor et al. 2000; Green, Watts et al. 2001; Lewis, Newall et al. 2001) report that walking distance derived from the incremental shuttle test is more closely correlated with peak VO2 than the six-minute walk test. This study demonstrates that the incremental shuttle walk test is both safe and well tolerated by patients with obstructive sleep apnoea. 
Our study showed that shuttle walking distance improved in CPAP compliant patients by clinically relevant amounts even within 2 weeks of therapy and that this improvement was sustained over a 6 month period of CPAP therapy. The improvement in walking distance was only found with CPAP compliance group, but not in poor CPAP compliance or CPAP intolerant group.Our findings are consistent with data from other studies (Lin, Lin et al. 2004) (Schlosser, Walther et al. 2006) (Konermann, Sanner et al. 1996) (Taguchi, Hida et al. 1997). Lin et al (Lin, Lin et al. 2004) evaluated cardiopulmonary responses to exercise in  patients with moderate to severe obstructive sleep apnoea following 2 months of CPAP therapy. They found that patients had cardiac dysfunction and abnormal measurements on cardiopulmonary exercise testing. Abnormalities in anaerobic threshold, VO2 peak and right ventricular ejection fraction (the degree of cardiac contraction function) improved after 2 months of CPAP treatment. Schlosser et al (Schlosser, Walther et al. 2006)  also evaluated cardiopulmonary exercise capacity in patients with obstructive sleep apnoea by using spiro-ergometry. They found that maximum oxygen uptake was significantly reduced in all patients with untreated OSA. After 6 months of CPAP therapy, a significant improvement in VO2max , arterial blood pressure and spirometric parameters were observed, whereas in CPAP-neglecting patients, serving as controls, no improvements were seen.A study by Taguchi et al (Taguchi, Hida et al. 1997) also examined the effect of CPAP on exercise performance in six patients with obstructive sleep apnoea by performing a bicycle ergometery. They found that maximum oxygen consumption was significantly increased within one week of CPAP therapy along with the improvement of sleepiness. However, there was no significant improvement in cardiovascular parameters at this time point. 
Our findings are not in agreement with some studies(Pendharkar, Tsai et al.; Alonso-Fernandez, Garcia-Rio et al. 2006; West, Kohler et al. 2009). West et al (West, Kohler et al. 2009) evaluated physical activity in patients with obstructive sleep apnoea before and  after 3 months of CPAP therapy. In this study physical activity was measured using wrist actigraphy.  This study found no significant increase in hourly physical activity following 3 months of CPAP therapy although they did demonstrate a significant improvement in subjective and objective assessment of daytime sleepiness. Alonso-Fernandez et al (Alonso-Fernandez, Garcia-Rio et al. 2006) performed a prospective randomised clinical trial in newly diagnosed OSAHS and evaluate cardiac response to exercise with cardiopulmonary exercise testing. Although there was a significant improvement in indices of left ventricular systolic response to exercise following 3 months of CPAP therapy, no significant changes in exercise capacity was seen in CPAP treated group. Recent prospective study (Pendharkar, Tsai et al.) conducted incremental exercise test in obese subjects with moderate to severe obstructive sleep apnoea treated by CPAP. It showed that dyspnoea and leg fatigue decreased significantly at 3 months of CPAP therapy. However peak oxygen consumption was unchanged.





6.1. Potential Mechanisms which may improve exercise capacity by CPAP
There are possible factors which may influence the outcome of exercise test such as change in body weight, physical fitness, coexistent illness, motivation, variation in CPAP compliance and change in physical activity level after initiation of CPAP. Factors which may contribute to the improvement of exercise capacity by CPAP include normalization of cardiac dysfunction, improved respiratory mechanics, increase fitness and other factors such as motivation and physical wellbeings. We did not attempt to elucidate the exact mechanism for increased exercise performance by CPAP. However, some of the findings may be the potential factors which may account for improved exercise capacity by CPAP treatment in patients with obstructive sleep apnoea.

6.1.1. Improvement in daytime sleepiness
Poor sleep quality due to repeated arousal leads to excessive daytime sleepiness in patients with obstructive sleep apnoea. Sleepy persons are reportedly more sedentary and are less motivated to engage in daily physical activities and social activities (Vanuxem, Badier et al. 1997; Grote, Hedner et al. 2004; Guillermo, Gal et al. 2006; Lin, Hsieh et al. 2006). Lack of habituation of exercise may result in lack of fitness and reduced exercise capacity in these groups. This study demonstrated improvements in daytime sleepiness (as recorded by ESS) in compliant patients within 2 weeks of initiation of CPAP. Sustained improvement was seen at 3 and 6 months. These results are compatible with randomised placebo control studies by Engleman et al (Engleman, Martin et al. 1998), Jenkinson et al (Jenkinson, Davies et al. 1999) and Montserrat et al (Monasterio, Vidal et al. 2001). A prospective randomised placebo controlled study by Engleman et al (Engleman, Martin et al. 1998) reported significant improvement in subjective sleepiness assessed by ESS and objective sleepiness assessed by MSLT in CPAP treated groups compared to placebo groups. Improved daytime symptoms may contribute to improve motivation and exercise performance. 
6.1.2. Improvements in psychological motivation 
Patients with obstructive sleep apnoea frequently report feeling tired, lacking in energy, experiencing fatigue and feeling poorly motivated to engage in physical and social activity. Assuming that psychological changes is crucial to motivating an individual to undertake strenuous physical activity some hypotheses can be advanced to explain how psychological profile influences exercise performance (Daley 2008). In our study, we could not find any significant improvement in depressive symptoms (as measured using the HADS score) following CPAP therapy. Henke et al (Henke, Grady et al. 2001) did not find any improvement in depression scores following a short treatment with CPAP (3 weeks). Similarly Engleman et al (Engleman, Kingshott et al. 1999) performed a randomised placebo-controlled study in patients with mild obstructive sleep apnoea and found no significant improvement in depression scores after 4 weeks of CPAP treatment.  The long term follow up studies of Borak et al (Borak, Cieslicki et al. 1996) and Munoz et al (Munoz, Mayoralas et al. 2000) also report no improvement in emotional status or depression scores after 12 months of CPAP treatment. However, Schwartz et al (Schwartz and Karatinos 2007) evaluated symptoms of depression using the Beck Depression Inventory in patients with moderate to severe obstructive sleep apnoea and CPAP therapy significantly decreased in symptoms of depression in both the short term and long term. Perhaps, as the tools employed to assess these symptoms vary between studies, a simple explanation for the variation in outcomes and findings is due to the varied sensitivities of the tools in detecting change in depression and anxiety scores. This area requires further future study.
6.1.3. Improvements in quality of life
Improvement in quality of life folowing CPAP treatment could be a possible explanation for improved exercise capacity. Quality of life can be defined as an individual’s sense of well-being and that of satisfaction within the areas of life that are important to them. Many studies suggest that patients with obstructive sleep apnoea have poor perceived health and physical function which can be reversed by effective CPAP treatment (Engleman, Martin et al. 1997; Engleman, Martin et al. 1998; Lacasse, Godbout et al. 2002; Reimer and Flemons 2003; Giles, Lasserson et al. 2006). In this study, subjects treated with CPAP showed a significant improvement in most subscales of the SF36 questionairre. A significant improvement in quality of life after CPAP treatment was seen especially in energy vitality score. 


6.1.4. Improvements in respiratory mechanics 
Most patients with obstructive sleep apnoea are obese. Obesity can cause decreased lung compliance (Behazin, Jones et al. ; Weiner, Waizman et al. 1998) which can decrease tidal volume at peak exercise. Obese patients have an increased sense of breathlessness which has a negative impact on exercise capacity (Parameswaran, Todd et al. 2006). Therefore a significant weight loss can result in the recruitment of  lung volume and function (Weiner, Waizman et al. 1998) with mproved lung compliance. In this study no significant decreases in weight or BMI were noted over the 6 months of CPAP therapy, although some subtle changes in anthropometrics were identified. 
There is growing evidence that CPAP improves respiratory function  ADDIN EN.CITE (de Miguel, Cabello et al. 2002; Sajkov, Wang et al. 2002; Heinzer, Stanchina et al. 2005; Sivan and Pelayo 2005). No patient assessed in this study had spirometric abnormalities sufficient to explain exercise limitation. We also did not find any significant differences in post exercise breathlessness before or after CPAP therapy in spite of improvement in walking distance. 


6.1.5. Improvements in cardiovascular parameters
Cardiovascular response to exercise is one of the primary determinant factors of an individuals exercise capacity and also a good prognostic indicator of cardiovascular mortality.Factors influencing cardiac responses to exercise include sinus node function, autonomic function and cardiac function. 32% of patients with OSAHS suffer from sinus node dysfunction (Marti Almor, Felez Flor et al. 2006) and OSA is also known to be associated with left ventricular dysfunction (Sin, Fitzgerald et al. 1999; Kenchaiah, Evans et al. 2002; Arias, Garcia-Rio et al. 2005) and autonomic dysfunction (Hedner, Ejnell et al. 1988; Carlson, Hedner et al. 1993; Somers, Dyken et al. 1995; Cole, Blackstone et al. 1999).The exact mechanisms explaining the association between obstructive sleep apnoea and abnormal cardiovascular responses to exercise are still unclear. Repeated hypoxia and hypercapnia are known to be associated with increase sympathetic activity (Launois, Averill et al. 2001; Lai, Yang et al. 2006; Zoccal, Bonagamba et al. 2007) in animal models. Some suggest that impaired cardiac response to exercise in obstructive sleep apnoea may be due to subtle changes in cardiac structure and function (Arias, Garcia-Rio et al. 2005; Wong, O'Moore-Sullivan et al. 2006).  Kaleth et al (Kaleth, Chittenden et al. 2007) evaluated the cardiopulmonary exercise response to exercise in normotensive patients with obstructive sleep apnoea finding this group to have a blunted heart rate response to exercise compared to control groups. Nasal CPAP has been shown to normalize cardiac autonomic responses to exercise and attenuate sympathetic nerve activity (Narkiewicz, Kato et al. 1999; Nelesen, Yu et al. 2001). Others  suggest  that CPAP has a positive impact on cardiac function (Konermann, Sanner et al. 1996) (Alonso-Fernandez, Garcia-Rio et al. 2006). 

6.1.5.1 Age predicted maximum heart rate
Age predicted maximum heart rate is one of the strongest factors to determine cardiovascular mortality. Our study found that only CPAP compliant group showed a significant increase in age predicted maximum heart rate achieved during exercise.The population based prospective Framingham Heart study (Lauer, Okin et al. 1996) found that failure to achieve 85% of the age-predicted maximum heart rate (chronotropic incompetence) was a predictor of all-cause mortality and incidence of coronary heart disease.Elhendy et al (Elhendy, Mahoney et al. 2003) studied also reported that failure to achieve 85% of maximum predicted heart rate was associated with cardiac death independent of LV function and severity of myocardial ischemia. Therefore it is tempting to speculate that these favourable cardiovascular changes following effective CPAP therapy may result in improvement in cardiovascular risk over time.


6.1.5.2. Heart rate recovery
Heart rate recovery after exercise is a function of parasympathetic activation and it has prognostic value in terms of cardiovascular mortality in patients with coronary heart disease (Gorelik, Hadley et al. 2006) and heart failure (Arena, Guazzi et al. 2006; Bilsel, Terzi et al. 2006). Heart rate recovery at 2 minutes is also known to be a stronger predictor of cardiovascular risk than heart rate recovery at 1 min (Gorelik, Hadley et al. 2006).  Maedar et al (Maeder, Munzer et al. 2008) evaluated cardiovascular exercise responses in untreated obstructive sleep apnoea patients reporting that heart rate recovery at one minute (HRR-1) was significantly lower in patients with severe obstructive sleep apnoea compared to patients with mild to moderate OSAS. Our study reports a significant improvement in heart rate recovery especially in CPAP compliance group which may suggest normalization of autonomic nervous activity by CPAP therapy. The similar result was seen in  studies by Alonso-Fernandez et al (Alonso-Fernandez, Garcia-Rio et al. 2006) and Nelesen et al (Nelesen, Yu et al. 2001). Alonso-Fernandez et al (Alonso-Fernandez, Garcia-Rio et al. 2006) evaluated cardiac responses to exercise in middle-aged obstructive sleep apnoea patients. CPAP therapy was associated with an increase in heart rate recovery compared to those receiving sham CPAP. Nelesen et al (Nelesen, Yu et al. 2001) studied the effect of CPAP in  OSA patients on cardiac contractility (sympathetic activity) and heart rate variability (parasympathetic activity) at rest and in response to a laboratory stressor on three occasions: before treatment, after one night of CPAP treatment and after 1 week after CPAP treatment. These results indicate that CPAP normalizes contractility and increases cardiac parasympathetic tone after 1 week treatment with CPAP. 
6.1.5.3. Improvements in resting and exercise associated blood pressure
Diastolic blood pressure elevation is a limiting factor for physical performance in patients with obstructive sleep apnoea. The exact mechanism is unknown. Repeated hypoxia and hypercapnia are known to be associated with increase sympathetic activity (Launois, Averill et al. 2001; Lai, Yang et al. 2006; Zoccal, Bonagamba et al. 2007) in animal model with repeated nocturnal desaturation being associated with elevated sympathetic activity leading to an exaggerated blood pressure response to exercise.  Tryfon et al (Tryfon, Stanopoulos et al. 2004) performed exercise testing in  normotensive OSA patients and normal controls. They found that patients with obstructive sleep apnoea had a significant higher peak diastolic blood pressure (DBP;115.3 ±9.2 mmHg) than that of normal subjects (101±8.4 mmHg, p<0.01). Moreover OSA patients who reached a DBP of 110 mmHg were found to have a significantly lower VO2max than normal controls. We found a significant reduction in resting diastolic blood pressure and more rapid recovery of diastolic blood pressure after exercise in CPAP compliant subjects. Our study also found a significant reduction in resting systolic and diastolic blood pressure following 6 months therapy of CPAP in CPAP compliant group. There is still debate as to whether CPAP can reduce blood pressure in the long term. Studies by Pepperell et al demonstrate long term reductions in blood pressure with CPAP therapy in patients with OSA as compared with untreated controls (Pepperell, Ramdassingh-Dow et al. 2002). 

6.3. Exercise as a treatment of obstructive sleep apnoea
The long term sustainable management of patients with obstructive sleep apnoea should be aimed at life style modification by encouraging weight loss and increasing physical activity in addition to CPAP treatment. Determination of exercise capacity not only clarifies the current status of physical fitness but also shows the effectiveness of exercise therapy. Regular exercise had a positive effect on body weight, AHI and quality of life (Norman, Von Essen et al. 2000). The American Sleep Apnoea Association recommends physical exercise as a non-pharmacological treatment strategy for patients with obstructive sleep apnoea (Driver and Taylor 2000). The mechanism by which physical activity improves the severity of obstructive sleep apnoea is uncertain. In chronic obstructive airway disease, inspiratory muscle training has shown to improve ventilatory muscle strength (Lotters, van Tol et al. 2002). Similarly exercise training may strengthen the pharyngeal musculature and diminish airway collapse (Whipp and Ward 1992). Another possibility is that exercise may promote redistribution of adipose tissue from pharyngeal regions to other areas (Schwartz, Gold et al. 1991; Mortimore, Marshall et al. 1998). Other expounded theories include alterations in biochemical, metabolic and thermoregulatory effects of physical exercise on patients with obstructive sleep apnoea (Driver and Taylor 2000; Vgontzas, Bixler et al. 2005; Santos, Tufik et al. 2007).





7. Limitations of the Study
 The main limitation of our study is that this was not a randomized control study. A randomization of subjects to CPAP and placebo may have increased the validity of results. However it was not deemed ethically justifiable to withold CPAP treatment to those who had symptomatic moderate to severe obstructive sleep apnoea.  Another disadvantage of the study is the relatively low number of subjects able to participate in, and complete, the study and to be maintained compliance with CPAP. However, the number and nature of the changes identified, even in this small group, might suggest that a powerful biological signal is present indicating the positive effects of CPAP in terms of improving exercise capacity and quality of life in this population.
Another limiting factor is the scoring procedure used to determine a diagnosis of OSAHS. We conducted overnight oximetry as the first line investigation in our sleep lab and proceeded to limited polysomnography only for individuals with an ODI of less than 10/hr with high ESS. Most previous studies scored the severity of sleep apnoea based on AHI (Alonso-Fernandez, Garcia-Rio et al. 2006; Lin, Hsieh et al. 2006; Schlosser, Walther et al. 2006). Therefore the different scoring procedures for OSAHS may result in differing catagorisation of disease severity and add to the heterogeneity of responses to therapy. Exercise responses are unlikely to be similar across the whole spectrum of OSAHS with the severity of AHI possibly influencing exercise capacity. 











Obstructive sleep apnoea is a common disorder. Continuous Positive Airway Pressure is the best available treatment option for symptomatic patients with moderate to severe OSAHS. We found an increase in exercise capacity, improvement in cardiac response to exercise and improvement in quality of life following CPAP therapy. We also found that patients can tolerate the incremental shuttle test without any complications and that this test has utility for measuring change and is simple to use in many clinical situations. 
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Appendix 1: The Epworth Sleepiness Scale
How likely are you to doze off or fall asleep in the following situations, in contrast to just feeling tired?
This refers to your usual way of life in recent times.
Even if you have not done some of these things, try to work out how they would have affected you.
Use the following scale to choose the most appropriate number for each situation.
0= No chance of dozing: 
1= slight chance of dozing: 
2= moderate chance of dozing: 





Sitting inactive in public place (e.g. a theatre or a meeting)	
As a passenger in a car for an hour without a break	
Lying down to rest in the afternoon when circumstance permit	
Sitting and talking to someone	
Sitting quietly after  a lunch without alcohol	




Appendix 2: The Multiple Sleep Latency Test

Appendix 3: The Maintenance of Wakefulness Test

Appendix 4: The OSLeR Test

1. Test is conducted in 40 minute sleep-resistance challenges in a dark room isolated from external noise and subject is asked to be lying in a semi-recumbent position and remain awake.
2.  By hitting a button placed on a box directly connected to a personal computer, the subject is instructed to respond to a visual stimulus (light-emitting diode flash) which appeared for 1 second every 3 seconds.
3.  A total of 800 stimulations per test are emitted in 40 minutes.


















Appendix 5: The BORG Dyspnoea Score
The Borg Scale is used to measure your sensation of breathlessness during various activities.  Monitoring your breathlessness can help you safely adjust your activity by speeding up or slowing down your movements.  It can also provide important information to your health care provider. We want you to look at the Borg scale as instructed by your nurse or therapist and choose the number that best describes your level of breathlessness.     
Important points to remember:
	You should never go higher than 4 on the scale.  If your breathlessness is “Somewhat Severe” or worse, you need to stop what you are doing and rest.
	If you are exercising and your breathlessness is only very, very slight (less than 1 on the scale), then you should work a little harder.
	You should use the scale to make note of any changes that occur and report them to your health care provider.  For example, an activity that made you very slightly breathless (1 on the scale) a month age now makes you moderately breathless (3 on the scale) or vise versa.  We encourage you to keep a log and show it to your health care provider.
 
SCALE	SEVERITY
0	No Breathlessness At All














Appendix 6: The Hospital Anxiety and Depression Scale (HADS) Zigmond and Snaith (1983)

Patients are asked to choose one response from the four given for each interview.   They should give an immediate response and be dissuaded from thinking too long about their answers.  The questions relating to anxiety are marked "A", and to depression "D".  The score for each answer is given in the right column.  Instruct the patient to answer how it currently describes their feelings.

A. I feel tense or 'wound up':            Scale
      Most of the time                              3
      A lot of the time                              2
      From time to time occasionally       1
      Not at all                                          0

D  I still enjoy the things I used to enjoy:
     Definitely as much                           0
     Not quite so much                            1
     Only a little                                       2
     Hardly at all                                      3

A  I get a sort of frightened feeling as if something awful is about to happen:
     Very definitely and quite badly         3
     Yes, but not too badly                        2
     A little, but it doesn't worry me         1
     Not at all                                            0

D  I can laugh and see the funny side of things:
     As much as I always could                0
     Not quite so much now                      1
     Definitely not so much now               2
     Not at all                                             3

A  Worrying thoughts go through my mind:
     A great deal of the time                      3
     A lot of the time                                 2
     From time to time, but not too often- 1
     Only occasionally                               0

D  I feel cheerful:
     Not at all                                            3
     Not often                                           2
    Sometimes                                          1
    Most of the time                                 0

A I can sit at ease and feel relaxed:
    Definitely                                           0
    Usually                                               1
    Not Often                                            2
    Not at all                                             3

D I feel as if I am slowed down:
    Nearly all the time                              3
    Very often                                          2
    Sometimes                                          1
    Not at all                                             0
  
A I get a sort of frightened feeling like 'butterflies' in the stomach:
    Not at all                                          0
    Occasionally                                    1
    Quite Often                                      2
    Very Often                                       3
  
D I have lost interest in my appearance:
    Definitely                                          3
   I don't take as much care as I should 2
   I may not take quite as much care     1
   I take just as much care as ever         0

A I feel restless as I have to be on the move:
   Very much indeed                             3
    Quite a lot                                         2
    Not very much                                  1
    Not at all                                           0
  
D I look forward with enjoyment to things:
    As much as I ever did                      0
    Rather less than I used to                 1
    Definitely less than I used to           2
    Hardly at all                                     3

A I get sudden feelings of panic:
    Very often indeed                            3
    Quite often                                       2
    Not very often                                  1
    Not at all                                          0
  
D I can enjoy a good book or radio or TV program:
   Often                                                0
  Sometimes                                        1
  Not often                                           2
 Very seldom                                      3

Scoring (add the As = Anxiety.  Add the Ds = Depression).  The norms below will give you an idea of the level of Anxiety and Depression.
0-7 = Normal




Appendix 7: The Short Form 36 (SF-36) questionnaire

The following questions ask you about your health, how you feel and how well you are able to do your usual activities

1.	In general, would you say your health is       (tick one)
                  Excellent          O
                  Very good        O
                  Good                O
                  Fair                   O
                                Poor                  O
2.	How would you rate your health in general now?  (tick one)
                               Much better        O
                           Somewhat better O
                           About the same   O
                           Somewhat worse O
                           Much worse         O
3.	Health and daily activities
The following questions are about activities that you might do during a typical days. Does your health limit you in these activities? If so, how much? (tick one answer on each line)
Activities	Yes, limited a lot 	Yes,limited a little	No,Not limited at all
Vigorous activities such as running, lifting heavy objects, participating in strenuous sports			
Moderate activities such as moving a table, pushing a vacuum cleaner, bowling or playing golf			
Lifting or carrying groceries			
Climbing several flights of stairs			
Climbing one flight of stairs			
Bending, kneeling or stooping			
Walking more than a mile			
Activities	Yes, limited a lot 	Yes,limited a little	No,Not limited at all
Walking half a mile			
Walking 100 yards			






4.	Have you had any of the following problems with your work or other regular daily activities as a result of your physical health?
                                               (Tick one answer on each line)
	Yes	No
Cut down on the amount of time you spent on work or other activities		
Accomplished less than you would like		
Were limited in the kind of work or other activities		
 Had difficulty in performing the work or other activities (e.g.it took extra effort)		

5.	Have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious)?
                                              (Tick one answer on each line)
	Yes	No
Cut down on the amount of time you spent on work or other activities		
Accomplished less than you would like		





6.	To what extent have your physical health or emotional problems interfered with your normal social activities with family, neighbours or groups? 
                                                  (Tick one answer)
                             Not at all            O
                             Slightly              O
                             Moderately        O 
                             Quite a bit          O
                             Extremely          O

7.	How much bodily pain have you had?        
                                                     (Tick one answer)  
           
                None                  O
                 Very mild           O
                 Mild                    O
                 Moderate            O   
                             Severe                O





8.	How much did pain interfere with your normal work (including work both outside the home and housework)?
                                                         (Tick one answer)
                          Not at all               O
                         A little bit               O
                         Moderately             O
                         Quite a bit               O


















9.	These questions are about how you feel and how things have been with you .(For each questions, please indicate the one answer that comes closest to the way have you have feelings.)
	All of the time	Most of the time	A good bit of time	Some of the time	A little of the time	None of the time
Did you feel full of life?						
Have you been a very nervous person?						
Have you felt so down in the dumps that nothing could cheer you up?						
Have you felt calm and peaceful?						
Did you have a lot of energy?						
Have you felt down-hearted and low?						
Did you feel worn-out?						
Have you been a happy person?						
Did you feel tired?						
Have your health limited your social activities (like visiting friends or close relatives)						

Health in general
10.	Please choose the answer that best describes how true or false each of the following statements is for you.
                                       (Tick one answer on each line)

	Definitely true	Mostly true	Not sure	Mostly false	Definitely false
I seem to get ill more easily than other people					
I am as healthy as anybody I know					
I expect my health to get worse					








Appendix 8: The GPPAQ
General Practice Physical Activity Questionnaire		
1.	Please tell us the type and amount of physical activity involved in your work. Please tick one box that is closest to your present work from the following five possibilities: 	
 	 	Please mark one box only
a	I am not in employment (e.g. retired, retired for health reasons, unemployed, full-time carer etc.)	 
b	I spend most of my time at work sitting (such as in an office)	 
c	I spend most of my time at work standing or walking. However, my work does not require much intense physical effort (e.g. shop assistant, hairdresser, security guard, childminder, etc.)	 
d	My work involves definite physical effort including handling of heavy objects and use of tools (e.g. plumber, electrician, carpenter, cleaner, hospital nurse, gardener, postal delivery workers etc.) 	 
e	My work involves vigorous physical activity including handling of very heavy objects (e.g. scaffolder, construction worker, refuse collector, etc.)	 
					
2.	During the last week, how many hours did you spend on each of the following activities?
		 Please mark one box only on each row
 	 	None	Some but less than 1 hour	1 hour but less than 3 hours	3 hours or more
a	Physical exercise such as swimming, jogging, aerobics, football, tennis, gym workout etc.	 	 	 	 
b	Cycling, including cycling to work and during leisure time	 	 	 	 





3.	How would you describe your usual walking pace?  Please mark one box only.
					
	Slow pace
(i.e. less than 3 mph)	 	Steady average pace	 
	Brisk pace	 	Fast pace
(i.e. over 4mph)	 
					
				 
					


Position


Effort

Nasal
Flow

HR

SaO2

P=0.18

P=0.42

P<0.001

P=0.60

P=0.38

P=0.02

P=0.84

P=0.93

P=0.03

P=0.57

P=0.76

P=0.24

P=0.87

P=0.29

P=0.03

P=0.88

P<0.001

P<0.001
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